Skip to content
healthcare.dev

FULVESTRANT

NDC 70771-1626, fulvestrant, injection, solution, from Zydus Lifesciences Limited.

Product NDC
70771-1626
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215234
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1626 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
70771-1626-8707711626082 SYRINGE, GLASS in 1 CARTON (70771-1626-8) / 5 mL in 1 SYRINGE, GLASS (70771-1626-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/151b948a-3106-497a-b1c7-479307faeb89

Use it

Look up 70771-1626 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1626 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.